Abstrakt: |
Nanchang, People's Republic of China, Asia, Blood Protein Disorders, Cancer, Drugs and Therapies, Health and Medicine, Hematologic Diseases and Conditions, Hematology, Hemic and Lymphatic Diseases and Conditions, Hemorrhagic Disorders, Hemostatic Disorders, Immunoproliferative Disorders, Lymphoproliferative Disorders, Multiple Myeloma, Myeloma, Oncology, Paraproteinemias, Pharmaceuticals, Pharmacology, Vascular Diseases and Conditions Keywords for this news article include: Nanchang, People's Republic of China, Asia, Blood Protein Disorders, Cancer, Drugs and Therapies, Health and Medicine, Hematologic Diseases and Conditions, Hematology, Hemic and Lymphatic Diseases and Conditions, Hemorrhagic Disorders, Hemostatic Disorders, Immunoproliferative Disorders, Lymphoproliferative Disorders, Multiple Myeloma, Myeloma, Oncology, Paraproteinemias, Pharmaceuticals, Pharmacology, Vascular Diseases and Conditions, Jiangxi Province People's Hospital. [Extracted from the article] |